RCEL

Health Care Sector Update for 05/30/2024: RCEL, INMB, XERS

Health care stocks were rising Thursday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each adding about 0.4%.

The iShares Biotechnology ETF (IBB) was up 0.5%.

In corporate news, Avita Medical (RCEL) shares jumped 10% after the US Food and Drug Administration approved its premarket approval supplement for its cell harvesting device, Recell Go, to treat thermal burn wounds and partial and full-thickness defects.

Xeris Biopharma (XERS) shares surged past 16% after the firm reported positive topline phase 2 data of its investigational XeriSol-formulated once-weekly subcutaneous levothyroxine for the treatment of adults with hypothyroidism.

INmune Bio (INMB) shares rose 1.4% after the company said it will join the broad-market Russell 3000 index July 1.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.